Newsroom

Sorted by: Latest
-

Freebirds’ Slow-Smoked Texas Brisket is Back for a Limited Time

DALLAS--(BUSINESS WIRE)--Hey Texas, we heard you missed it. Freebirds World Burrito is bringing back its fan favorite Slow‑Smoked Texas Brisket, and yeah, it’s right on time. Starting now, guests can once again dig into this craveable classic, available for a limited time at Freebirds locations everywhere. Slow‑smoked for hours and packed with rich, smoky flavor, this brisket isn’t here to play. It’s tender, it’s bold, and it fits right in wherever you want it - burritos, bowls, tacos, salads…...
-

CORRECTING and REPLACING QAD | Redzone Expands Collaboration with AWS and TCS to Accelerate AI-Driven Transformation and ERP Modernization

MIAMI--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. QAD | REDZONE EXPANDS COLLABORATION WITH AWS AND TCS TO ACCELERATE AI-DRIVEN TRANSFORMATION AND ERP MODERNIZATION This collaboration enables manufacturers to deploy AI-driven capabilities today, generate immediate value, and transition to a modern ERP environment on their own terms QAD | Redzone, the company delivering the leading manufacturing platform, powered by Agentic AI that...
-

ポルファーマ・バイオロジクスとTuteur、自己免疫疾患向けバイオシミラーに関するライセンス契約を締結

スイス・ツーク--(BUSINESS WIRE)--（ビジネスワイヤ） -- バイオシミラーの開発・製造を専門とするバイオ医薬品会社のポルファーマ・バイオロジクスは、アルゼンチンに本拠を置くTuteurと画期的なライセンス契約を締結したことを発表しました。この戦略的パートナーシップに基づき、Tuteurはブラジルを除くラテンアメリカ（LATAM）地域における自己免疫疾患向けバイオシミラーの独占的な商業化権を取得します。 ポルファーマ・バイオロジクスは、引き続き当該バイオシミラーの開発・製造の全責任を担います。Tuteurはライセンス対象地域における商業化、マーケティング、流通を担当します。今回の提携は、同地域における高品質で手頃な価格のバイオ治療薬への患者アクセスを拡大するという両社共通の決意を反映しています。 ポルファーマ・バイオロジクスのCEOであるAnjan Selz氏は、「Tuteurとの提携は、バイオシミラーへのアクセスを世界規模で拡大するという当社の使命を前進させる重要な一歩です。LATAMにおける同社の強力な地域専門知識と商業能力を活用することで、この重要な治療法を自己...
-

BeOne Medicines lidera o setor de oncologia na ASCO e na EHA 2026 com mais de 60 resumos científicos

SAN CARLOS, Califórnia--(BUSINESS WIRE)--A BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), empresa global de oncologia, anunciou hoje que mais de 60 resumos sobre neoplasias hematológicas e tumores sólidos foram aceitos para apresentação na Reunião Anual de 2026 da Sociedade Americana de Oncologia Clínica (ASCO), que ocorrerá entre 29 de maio e 2 de junho em Chicago, e no congresso de 2026 da Associação Europeia de Hematologia (EHA), que ocorrerá entre 11 e 14 de junho em Estocolm...
-

Polpharma Biologics y Tuteur firman un acuerdo de licencia para un biosimilar específico para el tratamiento de enfermedades autoinmunes

ZUG, Suiza--(BUSINESS WIRE)--Polpharma Biologics, una empresa biofarmacéutica líder especializada en el desarrollo y la fabricación de biosimilares, anuncia que acaba de firmar un acuerdo de licencia histórico con la empresa argentina Tuteur. En virtud de esta alianza estratégica, Tuteur obtendrá los derechos exclusivos para comercializar un biosimilar para el tratamiento de enfermedades autoinmunes en toda Latinoamérica (LATAM), excepto Brasil. Polpharma Biologics seguirá siendo totalmente res...
-

INTU Investigation: BFA Announces Intuit Investigation on behalf of Investors after 20% Stock Drop – Contact the Firm if You Lost Money

NEW YORK--(BUSINESS WIRE)--BFA Announces Intuit Investigation on behalf of Investors after 20% Stock Drop – Contact the Firm if You Lost Money...
-

Securities Fraud Investigation Into Hub Group, Inc. (HUBG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON HUB GROUP, INC. (HUBG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On February 5, 2026, Hub Group disclos...
-

Prestige Consumer Healthcare (PBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PRESTIGE CONSUMER HEALTHCARE (PBH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss...
-

Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On May 5, 2026, Azenta released its second quarter 2026 financial results, missing...
-

Alphatec Holdings, Inc. (ATEC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (NASDAQ: ATEC) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ALPHATEC HOLDINGS, INC. (ATEC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal righ...